6533b85efe1ef96bd12c0945
RESEARCH PRODUCT
Clinicopathological Significance of Syndecan-1 in Cholangiocarcinoma: A Study Based on Immunohistochemistry and Public Sequencing Data
Hauke LangMario SchindeldeckerDaniel WagnerBeate K. StraubWilfried RothTiemo S. GerberFabian BartschLisa-katharina Heuftsubject
<i>SDC1</i>Pathologymedicine.medical_specialtyanimal structuresArticleSyndecan 1SDC103 medical and health sciences0302 clinical medicinemedicineLymph nodeIntrahepatic Cholangiocarcinoma030304 developmental biology0303 health sciencesbusiness.industryGallbladderRCancersyndecan-1General Medicinemedicine.diseasecarbohydrates (lipids)medicine.anatomical_structure030220 oncology & carcinogenesisBiliary Intraepithelial NeoplasiaMedicineImmunohistochemistrybiomarkerPancreasbusinesscholangiocarcinomadescription
Background: Syndecan-1 (CD138
year | journal | country | edition | language |
---|---|---|---|---|
2021-06-01 | Journal of Clinical Medicine |